M, assuming sustained core demand while maintaining a conservative stance on newer, emerging channels. The next-generation ...

Rhythm (Nasdaq:IRTC) reported first-quarter financial results that came in ahead of the consensus forecast on Wall Street.

iRhythm Technologies increased its 2026 revenue and profit guidance after reporting a 26% year-over-year jump in first-quarter sales, fueled by broader electronic health record integration, AI-driven ...

Q, showing a company still centered on ambulatory cardiac monitoring in the U.S. Its business is built around patch-based ECG ...

iRhythm Technologies posted $199.4 million in Q1 revenue, a 26% year-over-year increase, and raised its 2026 revenue and adjusted EBITDA margin guidance. The company credited broad adoption of its Zio ...

Rhythm Technologies (NASDAQ:IRTC) reported what management described as a strong start to fiscal 2026, posting first-quarter ...

SAN FRANCISCO, April 30, 2026 (GLOBE NEWSWIRE) -- iRhythm Holdings, Inc. (NASDAQ: IRTC), a leading digital health care company focused on creating trusted solutions that detect, predict, and prevent ...

Two retrospective studies detected arrhythmias beyond 48 hours in 30% of patients post cardiac ablation and in 60% of ...

Rhythm (Nasdaq:IRTC) today announced findings from two real-world analyses supporting its long-term heart monitoring ...

Real-world data presented at HRS 2026 add to the body of evidence supporting a shift away from short-duration Holter monitoring toward up to 14 ...

Detailed price information for Irhythm Holdings Inc (IRTC-Q) from The Globe and Mail including charting and trades.

Cardiac monitoring belongs foundation of service line strategy to improve cardiovascular care access, reduce delays, and ...